Patent · US Active

Early mesoderm cells, a stable population of mesendoderm cells that has utility for generation of endoderm and mesoderm lineages and multipotent migratory cells (MMC)

US9175260B2 · kind B2 · utility

3Cited by
17References
40Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 30, 2008
Grant dateNov 3, 2015
Priority date
Expiry dateNov 8, 2030

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2506/02
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The present invention relates to the production of multipotent migratory cell (MMCs) which can be differentiated into mesoderm or endoderm lineages. Multipotent Migratory Cells (MMC) are stable and robust and can be passaged at least 20 times (perhaps indefinitely), can be recovered after freezing, reamplified and differentiated into multiple lineages. They are therefore storage stable. The method of producing these cells points to a way to generate a multipotent cell type (mesendoderm) from blastocycts for the generation of therapeutically useful cell types without going through a classical hESC state. The production of multipotent migratory cells, mesendoderm cells and mesoderm cells (Isl1+) is also described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.